Howe Jill Ann bought LCTX
March 10, 2025 · Form 4 insider transaction
Howe Jill Ann bought 750,000 shares of Lineage Cell Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
750,000
Price
$0.00
Total value
N/A
InsiderHowe Jill Ann
RoleOfficer
SecurityEmployee Stock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 10, 2025
Filing dateMarch 12, 2025
Shares owned after750,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
One quarter of the options shall vest on March 10, 2026, and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment.